According to a new market report published by Lucintel, the future of the E-prescribing market looks promising with opportunities in the hospitals, office-based physicians, and pharmaceuticals. The E-prescribing market is expected to grow with a CAGR of 21% from 2019 to 2024. The major growth drivers for this market are government initiatives & incentive programs, rising focus on the reduction of fraud and abuse of controlled substances, focus on reducing medication errors, and need to curtail escalating healthcare costs.
In this market, solutions and services are the major product segment. The solutions segment is further divided into integrated solutions and standalone solutions. The services segment is divided into support & maintenance services, implementation services, network services, and training & education services.
North America will remain the largest market over the forecast period due to government initiatives and incentive programs to promote the E-prescribing system, and rising demand for E-prescribing system in the United States.
Epic Systems, Cerner, Allscripts Healthcare Solutions, Athenahealth, Quality Systems, Medical Information Technology, Relay health, Surescripts-Rxhub, Henry Schein, Drfirst, Practice Fusion, Greenway Health, GE Healthcare, and Eclinical works are among the major manufacturers of E-prescribing market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the E-prescribing market by product, usage mode, delivery mode, end user, and region. Lucintel has prepared a comprehensive research report entitled "E-prescribing Market 2019-2024: Trends, Forecast, and Opportunity Analysis". This Lucintel report serves as a catalyst for growth strategy as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes a forecast for the E-prescribing market by product, usage mode, delivery mode, end users, and region as follows:
By Product [$M shipment analysis for 2013 – 2024]:
• Solutions
• Services
By Usage Mode [$M shipment analysis for 2013 – 2024]:
• Hand held devices
• Computer based device
By Delivery Mode [$M shipment analysis for 2013 – 2024]:
• Web & Cloud-based
• On-premise
By End User [$M shipment analysis for 2013 – 2024]:
• Hospitals
• Office-based Physicians
• Pharmaceuticals
By Region [$M shipment analysis for 2013 – 2024]:
• North America
o United States
o Canada
o Mexico
• Europe
o United Kingdom
o Germany
o France
o Italy
o Spain
• Asia-Pacific
o China
o India
o Japan
• Rest of the World (ROW)
o Brazil

This research report of more than 150 pages will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or click on this link…… or [email protected].
About Lucintel
Lucintel, the premier global management consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, growth consulting, M&A, and due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

This report answers following 11 key questions:
Q.1. What are some of the most promising potential, high-growth opportunities for the E-prescribing market by product (Solutions and Services), By Usage Mode (hand held devices, computer based device), delivery mode (web & cloud-based and on-premise), end user (hospitals, office-based physicians, and pharmaceuticals), and region (North America, Europe, Asia-Pacific, and Rest of the World (ROW))?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which regions will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the drivers and challenges of the E-prescribing market?
Q.5. What are the business risks and threats to the E-prescribing market?
Q.6. What are emerging trends in this E-prescribing market and the reasons behind them?
Q.7. What are some changing demands of customers in the E-prescribing market?
Q.8. What are the new developments in the E-prescribing market? Which companies are leading these developments?
Q.9. Who are the major players in this E-prescribing market? What strategic initiatives are being implemented by key players for business growth?
Q.10. What are some of the competitive products and processes in this E-prescribing area and how big of a threat do they pose for loss of market share via material or product substitution?
Q.11. What M & A activities have taken place in the last 5 years in this, E-prescribing market?